Dance-based Avenues to Advance Nonpharmacologic treatment of Chemotherapy Effects (DAANCE)

Up to 80% of breast cancer survivors experience chemotherapy-induced neuropathy that impairs quality of life and increases fall risk long into survivorship, yet treatment options for neuropathy remain limited. The successful treatment will target neurophysiologic mechanisms for restoring function while addressing patient-reported symptoms and participation in treatment. Toward this end, the investigators propose to study a noninvasive, social sensorimotor intervention - Adapted Argentine Tango - which targets motor control restoration, symptom alleviation, and treatment participation in concert.

Contact Us

For more information about this study, including how to volunteer, contact:

Jacqueline Prinz

Phone Number: 1-203-785-5977
jacqueline.prinz@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

CREATE A VOLUNTEER PROFILE

Trial Purpose and Description

This study will investigate a noninvasive, social, sensorimotor intervention which targets motor control restoration, symptom alleviation, and treatment participation in concert: partnered Adapted Argentine Tango (Tango). This project will expand the investigators' pilot work (R21-AG068831) into a multicenter clinical trial designed to investigate the effect of social dance on sensory relief, functional restoration, and key mechanisms of action among a diverse cohort of BC survivors suffering from chronic chemotherapy-induced sensorimotor deficits.

Eligibility Criteria

Inclusion Criteria:

Breast Cancer (BC) diagnosis of Stage I-IV including metastatic disease
completed taxane-based chemotherapy for BC at least 3 months ago (no limit on how long ago)
symptomatic for chemotherapy-induced neuropathy (self-report)
postural control score that indicates potential fall-risk
able to understand and comply with directions associated with testing and study treatments

Exclusion Criteria:

pre-existing vestibular dysfunction
poorly controlled diabetes (hgA1C>=8)
non-ambulatory (assistive and prosthetic devices allowed)
hearing impairment resulting in less than 10% hearing bilaterally
contraindication to participate in the experimental physical activity per the treating oncologist due to additional condition (e.g., herniated disc, unstable bone metastases)
currently in activity-based therapy (e.g., physical therapy, occupational therapy). May enroll if still meet eligibility criteria once activity-based therapy is complete.